In one paragraphArticle in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Vinícius Menezes BragaDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14049-900, SP, Brazil.ORCID 0009-0007-4373-4783 Paulo Henrique Fernandes PereiraDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14049-900, SP, Brazil.
Letícia de Araujo ApolinarioDepartment of Nursing in Hospital Care, Federal University of the Triângulo Mineiro, R. Vigário Carlos, 100, Uberaba 38025-350, MG, Brazil.ORCID 0000-0001-6915-5615 Deisy Mara Silva LongoDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14049-900, SP, Brazil.
Leandra Naira Zambelli RamalhoDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14049-900, SP, Brazil.
Sher AliDepartment of Food Engineering, School of Animal Science and Food Engineering, University of São Paulo, Av. Duque de Caxias Norte, 225, Pirassununga 13635-900, SP, Brazil.ORCID 0000-0002-4604-9702 Carlos Augusto Fernandes de OliveiraDepartment of Food Engineering, School of Animal Science and Food Engineering, University of São Paulo, Av. Duque de Caxias Norte, 225, Pirassununga 13635-900, SP, Brazil.ORCID 0000-0001-5779-5287 Fernando Silva RamalhoDepartment of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto 14049-900, SP, Brazil.ORCID 0000-0002-7529-466X Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/21603-1
6 · The paper itselfAbstract
Aflatoxins (AFs) are potent hepatotropic mycotoxins-AFB
Indexed as
AflatoxinsBile Duct NeoplasmsCholangiocarcinomaG1 Phase Cell Cycle CheckpointsS Phase Cell Cycle CheckpointsAflatoxin B1AnimalsCell ProliferationCyclin D1MaleRats, WistarTumor Suppressor Protein p53Aflatoxin B1AflatoxinsCyclin D1Tumor Suppressor Protein p53AFB1-dominant aflatoxin mixtureaflatoxinscyclin D1immunohistochemistryintrahepatic cholangiocarcinomaPCNAretinoblastoma proteinTP53β-catenin
Identifiers
PMID41591160
PMCPMC12846706
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390